AAAAAA

   
Results: 1-10 |
Results: 10
Pharmacokinetics of liposomal daunorubicin [DaunoXome] during a phase I-IIstudy in children with relapsed acute lymphoblastic leukaemia
Authors: Bellott, R Auvrignon, A Leblanc, T Perel, Y Gandemer, V Bertrand, Y Mechinaud, F Bellenger, P Vernois, J Leverger, G Baruchel, A Robert, J
Citation: R. Bellott et al., Pharmacokinetics of liposomal daunorubicin [DaunoXome] during a phase I-IIstudy in children with relapsed acute lymphoblastic leukaemia, CANC CHEMOT, 47(1), 2001, pp. 15-21
Acute myeloid leukemia (AML) in children: Results of the French trials
Authors: Schaison, G Auvrignon, A Michel, G Leblanc, T Baruchel, A Landman-Parker, J Thuret, I Bordigoni, P Esperou, H Perel, I Vannier, JP Le Gall, E Nelken, B Stephan, JL Mechinaud, F Couillault, G Leverger, G
Citation: G. Schaison et al., Acute myeloid leukemia (AML) in children: Results of the French trials, HEMAT BLOOD, 40, 2001, pp. 525-530
Prognosis of acute lymphoblastic leukemia (ALL) in childhood. Results of the French protocol FRALLE 93
Authors: Schaison, G Auclerc, MF Baruchel, A Leblanc, T Leverger, G
Citation: G. Schaison et al., Prognosis of acute lymphoblastic leukemia (ALL) in childhood. Results of the French protocol FRALLE 93, B ACA N MED, 185(1), 2001, pp. 149-162
The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families
Authors: Raz, T Labay, V Baron, D Szargel, R Anbinder, Y Barrett, T Rabl, W Viana, MB Mandel, H Baruchel, A Cayuela, JM Cohen, N
Citation: T. Raz et al., The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families, HUM MUTAT, 16(1), 2000, pp. 37-42
Use of recombinant human granulocyte colony-stimulating factor to increasechemotherapy dose-intensity: A randomized trial in very high-risk childhood acute lymphoblastic leukemia
Authors: Michel, G Landman-Parker, J Auclerc, MF Mathey, C Leblanc, T Legall, E Bordigoni, P Lamagnere, JP Demeocq, F Perel, Y Auvrignon, A Berthou, C Bauduer, F Pautard, B Schneider, P Schaison, G Leverger, G Baruchel, A
Citation: G. Michel et al., Use of recombinant human granulocyte colony-stimulating factor to increasechemotherapy dose-intensity: A randomized trial in very high-risk childhood acute lymphoblastic leukemia, J CL ONCOL, 18(7), 2000, pp. 1517-1524
Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients
Authors: Morschhauser, F Cayuela, JM Martini, S Baruchel, A Rousselot, P Socie, G Berthou, P Jouet, JP Straetmans, N Sigaux, F Fenaux, P Preudhomme, C
Citation: F. Morschhauser et al., Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: A multicenter study of 51 patients, J CL ONCOL, 18(4), 2000, pp. 788-794
Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM)
Authors: Michallet, M Thomas, X Vernant, JP Kuentz, M Socie, G Esperou-Bourdeau, H Milpied, N Blaise, D Rio, B Reiffers, J Jouet, JP Cahn, JY Bourhis, JH Lioure, B Leporrier, M Sotto, JJ Souillet, G Sutton, L Bordigoni, P Dreyfus, F Tilly, H Gratecos, N Attal, M Leprise, PY Demeocq, F Michel, G Buzyn, A Delmas-Marsalet, B Bernaudin, F Ifrah, N Sadoun, A Guyotat, D Cavazzana-Cavo, M Caillot, D De Revel, T Vannier, JP Baruchel, A Fegueux, N Tanguy, ML Thiebaut, A Belhabri, A Archimbaud, E
Citation: M. Michallet et al., Long-term outcome after allogeneic hematopoietic stem cell transplantationfor advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM), BONE MAR TR, 26(11), 2000, pp. 1157-1163
Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia
Authors: Arico, M Valsecchi, MG Camitta, B Schrappe, M Chessells, J Baruchel, A Gaynon, P Silverman, L Janka-Schaub, G Kamps, W Pui, CH Masera, G
Citation: M. Arico et al., Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia, N ENG J MED, 342(14), 2000, pp. 998-1006
Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French acute Lymphoblastic Leukaemia Group (FRALLE)
Authors: Donadieu, J Auclerc, MF Baruchel, A Perel, Y Bordigoni, P Landman-Parker, J Leblanc, T Cornu, G Sommelet, D Leverger, G Schaison, G Hill, C
Citation: J. Donadieu et al., Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French acute Lymphoblastic Leukaemia Group (FRALLE), BR J CANC, 83(12), 2000, pp. 1617-1622
Intravenously administered gamma-globulin for the treatment of reactive hemaphagocytic syndrome: a multicentric study to assess efficacy.
Authors: Larroche, C Bruneel, F Andre, MH Bader-Meunier, B Baruchel, A Tribout, B Genereau, T Zunic, P
Citation: C. Larroche et al., Intravenously administered gamma-globulin for the treatment of reactive hemaphagocytic syndrome: a multicentric study to assess efficacy., ANN MED IN, 151(7), 2000, pp. 533-539
Risultati: 1-10 |